Delisting risk
Sunshine Biopharma
Commercializer of Canadian generic medicines with early-stage oncology and antiviral research.
$1.14
After-hours close0.00 (0.00%)
At close$1.14(−10.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$1.15 | −$1.15 | 0.0% |
| Aug 2026 | −$1.20 | — | — |
| May 2026 | −$2.50 | −$2.50 | 0.0% |
| Apr 2026 | −$2.70 | −$3.00 | −11.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Apr 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.17 | — | — | $9.6M | — | — |
| Aug 13, 2026 | −$1.15 | −$1.15 | 0.0% | $9.3M | $9.3M | −0.4% |
| Aug 11, 2026 | −$1.20 | — | — | $8.7M | −$9.4M | −208.2% |
| May 13, 2026 | −$2.50 | −$2.50 | 0.0% | $8.1M | $8.1M | 0.0% |
| Apr 3, 2026 | −$2.70 | −$3.00 | −11.1% | $10.0M | $8.6M | −14.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 13, 2025 | ||||||
| Aug 12, 2025 | ||||||
| May 15, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 19, 2024 | ||||||
| Aug 16, 2024 | ||||||
| May 20, 2024 | ||||||
| Mar 28, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 11, 2023 | ||||||
| May 10, 2023 | ||||||
| Apr 4, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 6, 2022 | ||||||
| Mar 21, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 11, 2021 | ||||||
| Mar 30, 2021 | ||||||
| Nov 11, 2020 | ||||||
| Aug 19, 2020 | ||||||
| May 18, 2020 | ||||||
| Apr 30, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Aug 15, 2019 | ||||||
| May 20, 2019 | ||||||
| Apr 12, 2019 | ||||||
| Nov 16, 2018 | ||||||
| Aug 17, 2018 | ||||||
| May 21, 2018 | ||||||
| Apr 2, 2018 | ||||||
| Nov 15, 2017 | ||||||
| Aug 11, 2017 | ||||||
| May 12, 2017 | ||||||
| Apr 17, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Aug 16, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 25, 2016 | ||||||